John V. Oyler/LinkedIn
Aug 7, 2025, 21:02
John V. Oyler: Q2 2025 Marks Another Strong Quarter for BeOne Medicines
John V. Oyler, Founder, Chairman & CEO at BeOne Medicines, shared a post on LinkedIn:
“Today, we announced our Q2 2025 earnings, continuing to build on the momentum from earlier this year.
This quarter marked another strong performance for the company, driven by the dedication and innovation of our BeOne Medicines team.
I’m proud of the consistent progress we’re making as we deliver value for our customers and shareholders. Read the press release here.”
More posts featuring BeOne Medicine on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 7, 2025, 21:02
Aug 7, 2025, 20:53
Aug 7, 2025, 19:57
Aug 7, 2025, 19:49